Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.

Xian WangJamunarani VeeraraghavanChia-Chia LiuXixi CaoLanfang QinJin-Ah KimYing TanSuet Kee LooYiheng HuLing LinSanghoon LeeMartin J SheaTamika MitchellShunqiang LiMatthew J Ellis Susan G Hilsenbeck Rachel SchiffXiao-Song Wang

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Together, this study reveals the potential of therapeutic modulation of NLK for the management of the endocrine-resistant breast cancers with active NLK signaling.

Keyphrases

cancer therapy
tyrosine kinase
young adults
drug delivery
childhood cancer